Clinical Studies of Natural Antiviral Gene-Eden-VIR/Novirin Are Listed on PubMed, the Most Selective and Prestigious Database of Medical Studies

SARASOTA, Fla., Oct. 16, 2017 /PRNewswire/ -- Many people currently use herbal treatments to improve their health. However, some are still reluctant to use those treatments.  To discover why, a study asked 601 individuals about their perceptions of natural treatments. [1]  The analysis of the answers revealed that many doubted their efficacy.  The study also discovered that even when the participants recognized this efficacy, they assumed that natural treatments have a small effect, much smaller than drugs.  Finally, the analysis revealed that the participants assumed that their doctors are against natural treatments. [1]  A perspective article added to these discoveries by writing that people commonly say that "for many of the (natural treatments) on the market there is a lack of clinical data from good quality randomized controlled trials" that proves their efficacy. [2] It is clear that to convince the public to use herbal treatments, researchers need to conduct high quality clinical studies that prove their safety and efficacy, and to compare this safety and efficacy to those of drugs. 

The Center for the Biology of Chronic Disease (CBCD) recognized this need for high quality clinical studies that prove the safety and efficacy of herbal treatments.  To address this need, a team of scientists from the CBCD, headed by Dr. Hanan Polansky, decided to conduct such studies to test two herbal treatments: Gene-Eden-VIR and Novirin. To ensure that these studies are of high quality, the team followed the FDA guidelines for conducting clinical studies.  The team also decided to submit the results to major medical journals.  The CBCD is happy to announce that this process was successful.  So far, three papers were published in two major medical journals.  In addition, the abstracts of these papers were listed on the US National Library of Medicine (PubMed). [3] [4] [5]  PubMed is the most selective and prestigious database of medical papers in the world.  Such listing indicates that the listed clinical studies are of high quality, and can be trusted by the public in making decisions about health. In fact, Lilac Corp sees this listing as a stamp of approval of the medical profession for its products.

These studies are important for three reasons. 1. They establish that the herbal treatments Gene-Eden-VIR and Novirin are safe and effective.  2. They show that herbal treatments can be better than the leading drugs.  3. The studies teach how to test herbal treatments.

For more information on the studies, visit http://cbcd.net/, and on Gene-Eden-VIR/Novirin, visit: http://no-viren.com/.

Media Contact:
Rebecca Beris
Lilac Corp
585-250-9999

http://no-viren.com/

[1] Jain N, Astin JA. Barriers to acceptance: an exploratory study of complementary/alternative medicine disuse. J Altern Complement Med. 2001 Dec;7(6):689-96.

[2] Sarah Edwards, M. Jayne Lawrence, Colin Cable and Michael Heinrich, Use and efficacy of herbal medicines: Part 2-clinical effectiveness, The Pharmaceutical Journal, Vol. 289, p270. 

[3] Polansky H, Itzkovitz E, Javaherian A. Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases, Clin Transl Med. 2016; 5: 40.

[4] Polansky H, Javaherian A, Itzkovitz E. Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir, Drug Des Devel Ther. 2016; 10: 2713–2722.

[5] Polansky H, Itzkovitz E, Javaherian A. Human papillomavirus (HPV): systemic treatment with Gene-Eden-VIR/Novirin safely and effectively clears virus. Drug Des Devel Ther. 2017 Mar 3;11:575-583. 

SOURCE Lilac Corp